We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Clinical Omics – News and Features

Advances in Proteomics content piece image
Article

Advances in Proteomics

In this article, we will explore some of the recent advances in proteomics and their potential wider impact.
New Study Explores Potential Links Between Diet, Microbiome and Immune Response in Multiple Sclerosis  content piece image
News

New Study Explores Potential Links Between Diet, Microbiome and Immune Response in Multiple Sclerosis

A new study has adopted a multi-omics methodology to explore potential links between diet, the microbiome and the immune response in multiple sclerosis (MS). The results are published in EBioMedicine.
 Innovations in Single-Cell Proteomics Drive Advances in Disease Research content piece image
Industry Insight

Innovations in Single-Cell Proteomics Drive Advances in Disease Research

Single-cell technologies are transforming our knowledge of human health and disease. In this article, Gary Kruppa outlines the latest advances in single-cell proteomics.
Probing the Dark Matter of the Cancer Genome for Prognostic Biomarkers content piece image
News

Probing the Dark Matter of the Cancer Genome for Prognostic Biomarkers

Researchers have uncovered 166 prognostic biomarkers through machine learning analysis of long non-coding RNAs.
Insights Into Lung Tumor Biology and Potential Drug Targets content piece image
News

Insights Into Lung Tumor Biology and Potential Drug Targets

A team of researchers has developed the largest and most comprehensive molecular map to date of lung squamous cell carcinoma. The database, which brings proteomic, transcriptomic and genomic data together, can be used to find potential new drug targets and identify underlying disease mechanisms related to therapy resistance.
Mass Spectrometry Brings Resolving Power to Biopharma content piece image
Article

Mass Spectrometry Brings Resolving Power to Biopharma

In the early 20th century, mass spectrometry (MS) was used to measure the mass of atoms and demonstrate the existence of isotopes. Now, MS is used to study a broad range of molecules including small hydrocarbons, proteins, peptides, carbohydrates and DNA.
Probing Deep Into Tumor Tissues content piece image
News

Probing Deep Into Tumor Tissues

Researchers have analyzed more than 8,000 proteins in detail from fixed samples of lung cancer tissue using mass spectrometers.
Small vial on paper with chemical formulations.
Article

How a Mass Spectrometer Works, Types of Instrumentation and Interpreting Mass Spectral Data

In this article, we take a look at the fundamentals of mass spectrometry, how it works, variations that can be used at each stage of the process and how they can be combined to suit different sample types or analytical questions.
COVID-19 Multiomics Research: Strategies, Insights and Tools  content piece image
Article

COVID-19 Multiomics Research: Strategies, Insights and Tools

In this article, we explore multiomic approaches to COVID-19 research and explore some of the computational and statistical tools being developed to support multiomic analyses.
Whole Genome Sequencing Enables More Precise Diagnoses for Patients With Rare Diseases content piece image
News

Whole Genome Sequencing Enables More Precise Diagnoses for Patients With Rare Diseases

More than 1,200 people with rare diseases have received a diagnosis thanks to the integration of large-scale genomics into the Stockholm region's healthcare system.
Advertisement